Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iofi DHA+EPA is a nutritional supplement developed and marketed by Laboratorios Laproff. It is formulated with omega-3 fatty acids, specifically docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), alongside essential vitamins and minerals. The supplement is primarily indicated for nutritional support during pregnancy (prenatal health) to aid in fetal brain development and maintenance of cognitive function, as well as to support cardiovascular health in adults. It is delivered as an oral capsule and is classified as a nutraceutical product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Iofi DHA+EPA.